- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Kwality Pharmaceuticals Ltd — Board Meeting, 12-02-2026: Board Meeting
12-02-2026 | 11:56 am
12-02-2026 | 11:56 am
Kwality Pharma announced its board approved robust Q3 & 9M FY26 financial results. Q3 revenue surged 46% to ₹123 Cr, PAT jumped 78% to ₹16 Cr. 9M revenue hit ₹346 Cr, PAT ₹42 Cr. Company targets ₹500 Cr revenue for FY26.
No comments yet. Be the first to comment!